why choose us

First received: May 11, 2023

Clinical Trial: Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA Vaccine Candidate Variations in Healthy Adults

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Influenza

Study Type: INTERVENTIONAL


Official Title: A Phase 2, Randomized, Active-Controlled, Observer-Blind, Dose-Ranging Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA Vaccine Candidate Variations in Healthy Adults 18 to 49

Brief Summary: The main purpose of the study is to evaluate the safety, reactogenicity, and the immunogenicity of mRNA-1010 vaccine candidate variations.

Read more